Follow

Cyxone AB

Nasdaq First North GM Stockholm (Sweden)

Cyxone is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
CYXO
SE0007815428
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Cyxone AB with ticker CYXO
Status
Active
Amount of instruments
63 677 056
Currency
SEK
First trading date
07 Jun 2016
Exercise
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
CYXO
SE0007815428
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Cyxone AB with ticker CYXO
Status
Active
Amount of instruments
63 677 056
Currency
SEK
First trading date
07 Jun 2016
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CYXO TO1
SE0008268072
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Cyxone AB with ticker CYXO TO1
Status
Archived
Amount of instruments
Currency
SEK
Trading period
07 Jun 2016 - 08 Feb 2017
Terms
One (1) warrant TO1 entitles the holder to subscribe for one (1) new share in the Company.
Update (30.01.2017): Today, the subscription period with the support of warrants of series TO 1 will commence.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CYXO TO2
SE0008268080
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Cyxone AB with ticker CYXO TO2
Status
Archived
Amount of instruments
Currency
SEK
Trading period
07 Jun 2016 - 27 Sep 2017
Terms
One (1) warrant of series TO 2 entitles the holder to subscribe for a one (1) new share for SEK 5 during the subscription period from September 18, 2017 until September 29, 2017.
Update (18.09.2017): Today, the subscription period with the support of warrants of series TO 2 will commence.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CYXO TO3
SE0011751817
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Cyxone AB with ticker CYXO TO3
Status
Archived
Amount of instruments
17 735 034
Currency
SEK
Trading period
20 Dec 2018 - 16 Sep 2019
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which will be the volume weighted average share price during the period from August 19, 2019 until August 30, 2019, with a discount of twenty-five (25) percent. The subscription price cannot be lower than SEK 3.75 or higher than SEK 7.50 per share. The subscription period with the support of warrants is scheduled to be from September 2 - September 18, 2018.
Update (30.08.2019): The exercise price has been set to SEK 5.37 per share.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CYXO TO4
SE0015195854
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Cyxone AB with ticker CYXO TO4
Status
Archived
Amount of instruments
4 700 000
Currency
SEK
Trading period
30 Nov 2020 - 21 May 2021
Terms
Each warrant of series TO4 will give the holder the right to subscribe for one (1) new share in Cyxone at a subscription price corresponding to 70 percent of the average volume-weighted share price on Nasdaq First North Growth Market Sweden during the period from April 29, 2021 to May 12, 20211. However, the subscription price shall not exceed SEK 7.05 per new share, and not be less than SEK 2.00 per share. The exercise period for the subscription of new shares with warrants of series TO4 will be from May 17, 2021 up until May 28, 2021.
Update (27.11.2020): First day of trading with warrants of series TO4.
Update (14.05.2021): Subscription price for exercising warrants of series TO4 has been set - SEK 3.24.
Update (21.05.2021): Last trading day for warrants TO4.
Exercise
Sign in to buy
People
Carl-Magnus Högerkorp
CEO
Bert Roland Kari Junno
Chairman of the board
Theresa Comiskey Olsen
Board member
Saad Urrehman Gilani
Board member
Mikael Lindstam
Board member
Alejandra Mørk
Board member
Peter Heinrich
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Adelgatan 21
Zip code
211 22
City/district
Malmö
Country
Sweden (SE)
Registration number
559020-5471
LEI code
54930034OH16ROAY4K87
First trade date
07 Jun 2016
Registration date
13 Jul 2015
Short name
CYXO

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More